Persistent pulmonary disease after acute covid-19.

Fraser, Emily

Fraser, Emily.

Fraser E; Churchill Hospital, Oxford, UK Emily.Fraser@ouh.nhs.uk.

BMJ ; 373: n1565, 2021 06 21.

Article in English | MEDLINE | ID: covidwho-1280416

Subject(s)

COVID-19/complications; Lung Diseases, Interstitial/epidemiology; Lung/diagnostic imaging; Pulmonary Veno-Occlusive Disease/epidemiology; SARS-CoV-2/pathogenicity; COVID-19/diagnosis; COVID-19/immunology; COVID-19/virology; Follow-Up Studies; Health Status; Humans; Incidence; Lung/blood supply; Lung/immunology; Lung/pathology; Lung Diseases, Interstitial/diagnosis; Lung Diseases, Interstitial/immunology; Lung Diseases, Interstitial/virology; Observational Studies as Topic; Pulmonary Veno-Occlusive Disease/diagnosis; Pulmonary Veno-Occlusive Disease/immunology; Pulmonary Veno-Occlusive Disease/virology; SARS-CoV-2/immunology; SARS-CoV-2/isolation & purification; Severity of Illness Index

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pulmonary Veno-Occlusive Disease / Lung Diseases, Interstitial / SARS-CoV-2 / COVID-19 / Lung Type of study: Diagnostic study / Incidence study / Observational study / Prognostic study / Risk factors Topics: Long Covid Limits: Humans Language: English Journal: BMJ Journal subject: Medicine Year: 2021 Document Type: Article Affiliation country: Bmj.n1565

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google